BioSpace News Archive

Drug Development

Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed (ALIMTA®) and Platinum Chemotherapy Reduced the Risk of Death by Half Compared with Chemotherapy Alone as First-Line Treatment for Advanced Nonsquamous NSCLC in Phase 3 KEYNOTE-189 Study

KEYTRUDA Combination Improved Overall Survival in Patients Regardless of PD-L1 Expression, Including Patients Who Tested Negative for PD-L1 Results Presented Today at AACR 2018 and Published in The New England Journal of Medicine Also Show Significant Improvement in Progression-Free Survival, with Risk of Progression or Death Reduced by Nearly Half

April 16, 2018
·
31 min read
Business

NextPhase Medical Devices Launches New Business

Carlo W. Colesanti, President and CEO, announced today the launch of NextPhase Medical Devices LLC

April 16, 2018
·
3 min read
Business

Genomma Lab (BMV: LAB.B) First Quarter 2018 Results Conference Call

Genomma Lab invites you to its First Quarter Conference Call and Webcast.

April 16, 2018
·
2 min read
Grifols donates over 25 million international units of blood clotting factor in 2017

Part of an eight-year commitment to WFH; Changing the lives of people with hemophilia in 47 countries with limited access to treatment

April 16, 2018
·
4 min read
Business

BIOQUAL Presents Financial Results for Third Quarter of Fiscal Year 2018

BIOQUAL Presents Financial Results for Third Quarter of Fiscal Year 2018

April 16, 2018
·
2 min read